Arvin Yang
2022
Compensation breakdown
| Non-Equity Incentive Plan | $245,450 |
|---|---|
| Option Awards | $582,726 |
| Salary | $527,850 |
| Stock Awards | $177,931 |
| Other | $7,000 |
| Total | $1,540,957 |
Yang received $582.7K in option awards, accounting for 38% of the total pay in 2022.
Yang also received $245.5K in non-equity incentive plan, $527.9K in salary, $177.9K in stock awards and $7K in other compensation.
Rankings
In 2022, Arvin Yang's compensation ranked 2,172nd out of 5,760 executives tracked by ExecPay. In other words, Yang earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,172 out of 5,760 | 62nd |
Division Manufacturing | 1,170 out of 3,136 | 63rd |
Major group Chemicals And Allied Products | 504 out of 1,422 | 65th |
Industry group Drugs | 464 out of 1,323 | 65th |
Industry Pharmaceutical Preparations | 338 out of 969 | 65th |
Pay ratio
| Arvin Yang's Pay | $1,540,957 |
|---|---|
| Median Employee's Pay | $243,051 |
| Pay Ratio | 6to 1 |
In 2022, the annual total compensation of Arvin Yang was $1,540,957.
The annual total compensation of the median employee at Mersana Therapeutics was $243,051.
The ratio of Arvin Yang's pay to the pay of median employee was therefore 6 to one.
Yang's colleagues
We found four more compensation records of executives who worked with Arvin Yang at Mersana Therapeutics in 2022.
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021